Dr. Gregg Day speaks with Pam Belluck, an award-winning
journalist at the New York Times, about her coverage of the recent
FDA approval of aducanumab for Alzheimer disease treatment.
The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.